arcotatug tavatecan

Latest Post

Biogen Q3 2026 Results: Revenue Rises 11% as Company Raises Earnings Guidance Nucelion and Pandorum Partner on ₹17 Crore Eye-Therapy Research Programmes Vera Health Raises $28.5 Million to Expand Its Clinical AI Search Platform Hundreds of UK GP Websites Hit by Healthcare Technology Provider Collapse India Revises Prices of 543 Cancer-Medicine Brands: New Rates From November 9

Takeda Gastric Cancer Drug Trial: Survival Reaches 10.2 Months

October 26, 2026 Simone Lamb

The Takeda gastric cancer drug trial found arcotatug tavatecan lifted median survival to 10.2 months versus 6.9. Results, safety and open questions.

You missed

Biogen Q3 2026 Results: Revenue Rises 11% as Company Raises Earnings Guidance

October 29, 2026 Simone Lamb

Nucelion and Pandorum Partner on ₹17 Crore Eye-Therapy Research Programmes

October 29, 2026 Simone Lamb

Vera Health Raises $28.5 Million to Expand Its Clinical AI Search Platform

October 29, 2026 Simone Lamb

Hundreds of UK GP Websites Hit by Healthcare Technology Provider Collapse

October 29, 2026 Simone Lamb